GE HealthCare Technologies Inc. GEHC recently introduced CareIntellect for Operations, an AI-powered Software-as-a-Service (SaaS) application that enables health systems to anticipate capacity challenges up to 72 hours ahead and proactively manage emerging operational bottlenecks. The Queen’s Health Systems and Duke Health will be the first health systems to implement the application.
CareIntellect for Operations is part of GE HealthCare’s CareIntellect family of clinical and operational applications, which use a common cloud-first infrastructure. The application runs on Amazon Web Services (AWS) and is available directly from GE HealthCare and through the AWS Marketplace.
Per GE HealthCare management, CareIntellect for Operations is designed to help health systems identify where operational pressure is building and determine the appropriate next steps. The solution combines patient and operational data with proprietary AI models to provide predictive insights and workflow-connected recommendations, supporting efforts to optimize resources and manage capacity at critical decision points.
GEHC Stock Trend Following the News
Following the announcement, GEHC stock lost 0.3% at yesterday’s close. Year to date, shares of the company have fallen 21.9% compared with the industry’s 21.2% decline. However, the S&P 500 has risen 11.1% in the same timeframe.
The launch of CareIntellect expands GE HealthCare’s portfolio of AI-enabled SaaS applications for health systems and could support further adoption of its digital healthcare solutions. The ability to forecast operational constraints and recommend actions across capacity and throughput may help health systems improve resource utilization and address bottlenecks proactively, creating additional opportunities for GEHC in healthcare technology.
GEHC currently has a market capitalization of $29.02 billion.
Image Source: Zacks Investment Research
More on CareIntellect for Operations
CareIntellect for Operations analyzes hundreds of patient- and operational-level data points, including bed availability, patient delays, staffing, wait times and ancillary services. It provides unit-, department- and enterprise-level views of emerging constraints and is designed to help operational leaders address areas such as discharge, imaging, transfers and capacity.
The application uses two proprietary GEHC AI models. The Pressure Forecast model combines historical hospital operations data with real-time information from electronic medical records (EMRs) and other resource management systems to predict potential constraints across hospitals, departments and units up to 72 hours ahead.
The Estimated Day of Discharge model analyzes longitudinal patient data to estimate when individual patients are likely to be discharged. These estimates are updated hourly as new information becomes available, while recommended actions and prioritized workflows are surfaced to help teams mitigate emerging operational pressure.
The Queen’s Health Systems and Duke Health, serving as the first clinical evaluation sites, will provide frontline feedback to inform future enhancements. CareIntellect for Operations also builds on more than two decades of GE HealthCare’s hospital operations expertise, including its Command Center software, which is used by nearly 500 hospitals and medical facilities globally.
Industry Prospects Favoring the Market
Going by the data provided by Markets and Markets, the global AI in hospital operations market was valued at $7.51 billion in 2025 and is expected to witness a CAGR of 27.9% through 2030.
Factors such as workforce shortages, rising administrative burdens and the growing need to improve hospital operational efficiency while maintaining quality of care are expected to drive market growth. The increasing adoption of AI-based predictive and decision-support solutions could further support demand for technologies aimed at optimizing capacity, patient flow and resource utilization.
Other News
GE HealthCare recently announced that it is taking its next-generation StarGuide GX digital 4D cadmium zinc telluride (CZT) SPECT/CT system closer to the U.S. market with the submission to the FDA for 510(k) clearance. Following its recent CE Mark, the milestone marks continued progress toward expanding access to next-generation molecular imaging technologies and supporting a broader range of nuclear medicine applications.
GE HealthCare Technologies Inc. Price
GE HealthCare Technologies Inc. price | GE HealthCare Technologies Inc. Quote
GEHC’s Zacks Rank & Other Key Picks
Currently, GEHC carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks from the broader medical space are Veracyte VCYT, Globus Medical GMED and Inspire Medical Systems INSP, each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Veracyte reported a second-quarter 2026 adjusted earnings per share (EPS) of 54 cents, which surpassed the Zacks Consensus Estimate by 25.6%. Revenues of $150.3 million beat the Zacks Consensus Estimate by 4.1%.
VCYT has an estimated earnings growth rate of 8.4% for 2026. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 41.8%.
Globus Medical reported a second-quarter 2026 adjusted EPS of $1.34, which surpassed the Zacks Consensus Estimate by 19.6%. Revenues of $789.6 million beat the Zacks Consensus Estimate by 0.4%.
GMED has an estimated long-term earnings growth rate of 12.4%. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 27.9%.
Inspire Medical reported second-quarter 2026 adjusted EPS of 14 cents, which beat the Zacks Consensus Estimate by 163.6%. Revenues of $200.6 million surpassed the Zacks Consensus Estimate by 2.9%.
INSP has an estimated long-term earnings growth rate of 10.6%. INSP’s earnings surpassed estimates in the trailing four quarters, the average surprise being 195.9%.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
GE HealthCare Technologies Inc. (GEHC): Free Stock Analysis Report
Globus Medical, Inc. (GMED): Free Stock Analysis Report
Veracyte, Inc. (VCYT): Free Stock Analysis Report
Inspire Medical Systems, Inc. (INSP): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).